Compounds > triethylenemelamine
Page last updated: 2024-11-06

triethylenemelamine and Osteogenic Sarcoma

triethylenemelamine has been researched along with Osteogenic Sarcoma in 2 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FEIND, CR1
HERTER, F1
MARKOWITZ, A1
Thompson, RW1
Small, RC1
Stein, JJ1

Other Studies

2 other studies available for triethylenemelamine and Osteogenic Sarcoma

ArticleYear
IMPROVEMENTS IN ISOLATION HEAD PERFUSION.
    American journal of surgery, 1963, Volume: 106

    Topics: Carcinoma, Squamous Cell; Carotid Arteries; Chemotherapy, Cancer, Regional Perfusion; Child; Chordom

1963
Treatment of retinoblastoma.
    The American journal of roentgenology, radium therapy, and nuclear medicine, 1972, Volume: 114, Issue:1

    Topics: Cataract; Child; Child, Preschool; Eye Neoplasms; Female; Humans; Infant; Male; Neoplasm Metastasis;

1972